MAPK7 and prostate carcinoma: BMK1 expression is increased in CRPC, however, since many receptor tyrosine kinases are activated by BMK1 in prostate cancer [119], the relative importance of BAK phosphorylation for CRPC compared to other BMK substrates is difficult to evaluate.